33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extended letermovir prophylaxis is highly effective cytomegalovirus (CMV) infection prevention in adult cord blood transplantation (CBT) recipients & does not prevent emergence of CMV-specific donor-derived immunity
    Meeting Abstract

    Politikos, I.; Lau, C.; Devlin, S. M.; Naputo, K.; Quach, S.; Chinapen, S.; Lin, A.; Papadopoulos, E. B.; Perales, M. A.; Shah, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Defining a role: Clinical Nurse Coordinator Task Force
    Meeting Abstract

    McLoughlin, C.; Dunn, E.; Gaa, E.; Inumerables, F.; Gilroy, C.; Taylor, J.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Assessing mental health to improve the unrelated donor experience through be the match
    Meeting Abstract

    Kasow, K. A.; Squire, C. M.; Lubitz, M.; Wells, D. S.; Ikenberry, K.; Byrne, N.; Bohachek, H.; Smolich, J.; Margolis, J.; Albert, C.
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Humoral immunogenicity of SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A CIBMTR and BMT CTN study
    Meeting Abstract

    Riches, M. L.; Hill, J. A.; Martens, M.; Auletta, J. J.; Baluch, A.; Bhavsar, K.; Brown, J.; Dhodapkar, M. V.; DiFronzo, N.; Howard, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with large B-cell lymphoma treated with standard-of-care axicabtagene ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium
    Meeting Abstract

    Spiegel, J.; Dahiya, S.; Nastoupil, L. J.; Tamaresis, J.; Ghobadi, A.; Lin, Y.; Lekakis, L. J.; Reagan, P. M.; Oluwole, O. O.; McGuirk, J. P.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization
    Meeting Abstract

    Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Transplant providers’ perceptions of COVID-19 vaccination in the wake of a global pandemic
    Meeting Abstract

    Spallone, A.; Khawaja, F.; Ariza-Heredia, E.; Papanicolaou, G. A.; Boeckh, M. J.; Dadwal, S. S.; Abidi, M. Z.; Camargo, J. F.; El Boghdadly, Z.; Shahid, Z.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • The amphiregulin/EGFR axis regulates donor T cell expansion and contributes to intestinal GVHD pathology after allogeneic bone marrow transplantation
    Meeting Abstract

    Ito. T.; Takashima, S.; Calafiore, M.; Fu, Y. Y.; Egorova, A.; Kuttiyara, J.; Chang, W.; Vinci, P.; Arnhold, V.; Zaiss, D.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Meeting Abstract

    Dahi, P. B.; Geyer, A.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Two-year (yr) follow-up (FU) of Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) in relapsed or refractory (R/R) large B-cell lymphomas (LBCL)
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M.; Wang, M.; Arnason, J.; Purev, E.; Maloney, D. G.; Andreadis, C.; Sehgal, A. R.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save